MindImmune Nets Innovation Voucher

mindimmune-logo-100x100pxMindImmune Therapeutics, Inc., a biotech startup based at URI in partnership with the Ryan Institute, was one of six companies to receive innovation vouchers from the Rhode Island Commerce Corp. The vouchers are intended to spur research and development partnerships; MindImmune’s $50,000 voucher will fund collaboration with the URI Comparative Biology Resources Center. MindImmune is exploring neuroimmunology-based drug therapies for Alzheimer’s disease and other neurodegenerative diseases.

Read more at the Providence Business Journal (subscription required) and GoLocalProv.